Defining clinically important bleeding outcomes for clinical trials in hematological malignancies: perceptions of patients and health care providers
Defining clinically important bleeding outcomes for clinical trials in hematological malignancies: perceptions of patients and health care providers
定义血液恶性肿瘤临床试验的临床重要出血结果：患者和医疗保健提供者的看法
批准号：
435813
负责人：
Hillis Christopher M
金额：
$16.44万
依托单位：
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-10-01 至 2023-10-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patients with acute leukemia bleed more easily due to the disease and its treatments. Researchers use bleeding as an outcome in clinical trials to test new products and better ways to prevent bleeding in these patients. Currently there are four categories
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
